The First Company to use Genomic Data for Fitness Recommendations. Should other Companies Take Note?

There is no doubt that improved technologies have greatly reduced the amount of time necessary to sequence human genomes. In the past, it would take weeks or even months to sequence a single person’s genome. Modern technology has greatly improved our capabilities, and the entire genome can now be sequenced in just a few hours. No longer is it cost or time prohibitive to sequence human genomic data. Now that the technology is present to obtain genomic data, companies have begun to capitalize. 

The first example of commercialization of genomic data was with companies like 23AndMe and Ancestry.com, who use genomic data to allow consumers to learn more about their ancestral roots. Then, a few months ago, we wrote about DNANudge, a London-based company who uses genomic data to make recommendations and suggestions for purchasing foods that will fit best with a given person’s genes. 

Now, a new use for genomic data has emerged: Exercise Plans Catered to your Genomic Data. This past week, FitnessGenes LTD. had their second application published (US. Pat. Pub. No. 20210050086). The application teaches a method of “generating an optimized workout plan for an individual based on the individual’s genetic, physiological, behavioral and lifestyle data.” Using a person’s genetic data, the system taught in the ‘0086 application will provide personalized workout plans that produce the best results based on a user’s genetic profile, even more tailored than a professional fitness trainer can provide. 

Whether using genetic data to create personalized recommendations is just a fad, or a technology that is here to stay is still to be determined. That being said, there are likely many more applications for this technology that have yet to be claimed. Make sure to check back to the AI Biotech/Diagnostics Patent Forecast® regularly to see what other uses for human genetic data emerge in the quickly growing field of gene-based recommendations.

 

Related Posts

Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees

Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…


Capital One is Investing in AI Biotech? What’s in their wallet?

In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…


Google AI Reinvents Speech Recognition. Who will follow?

There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…